Literature DB >> 2238661

Multifactorial analysis of survival in primary extremity liposarcoma.

H R Chang1, J Gaynor, C Tan, S I Hajdu, M F Brennan.   

Abstract

The treatment of extremity soft tissue sarcoma is now directed at limb preservation with the addition of various adjuvant therapies to improve treatment results. To achieve this goal, a knowledge of prognostic factors for extremity soft tissue sarcoma becomes increasingly critical. The object of this study was to analyze prognostic factors for survival in patients with extremity liposarcoma. Eighty-three patients with primary localized extremity liposarcoma, admitted from 1968 to 1978, were retrospectively reviewed. Surgical resection was the primary mode of treatment. Eleven prognostic factors were analyzed. Tumor factors included: histologic subtype, tumor grade, size, depth, invasion of vital structures, and site; operative factors included: type of operation, and surgical margins; and patient factors included: symptoms, age at diagnosis, and sex. Kaplan-Meier survival curves, and univariate and stratified log-rank tests of association were performed. Independent factors for predicting survival were identified using the Cox model stepwise regression technique. In univariate analysis of the entire group of patients, 5 factors were significant for tumor mortality: tumor grade (p = 0.00005), histologic subtype (p = 0.00025), tumor size greater than or equal to 5 cm (p = 0.005), type of surgery/margin (p = 0.0001), and invasion of vital structures (p = 0.008). When associations among all factors were analyzed, it was found that many factors were interdependent. The independent prognosticators were, therefore, determined according to the Cox model technique. For the multivariate analysis, well-differentiated and lipoblastic liposarcomas were excluded because of lack of survival variation within each group. The former group had no tumor-related deaths and the latter group showed 80% tumor mortality.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2238661     DOI: 10.1007/bf01658804

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  20 in total

1.  A clinical and pathological staging system for soft tissue sarcomas.

Authors:  W O Russell; J Cohen; F Enzinger; S I Hajdu; H Heise; R G Martin; W Meissner; W T Miller; R L Schmitz; H D Suit
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  Identification and assessment of prognostic factors.

Authors:  S L George
Journal:  Semin Oncol       Date:  1988-10       Impact factor: 4.929

3.  Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma.

Authors:  C F Collin; C Friedrich; J Godbold; S Hajdu; M F Brennan
Journal:  Semin Surg Oncol       Date:  1988

4.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

5.  Liposarcoma of the musculoskeletal system.

Authors:  G G Orson; F H Sim; H M Reiman; W F Taylor
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

6.  Prospective study of cardiomyopathy induced by adjuvant doxorubicin therapy in patients with soft-tissue sarcomas.

Authors:  S E Ettinghausen; R O Bonow; S T Palmeri; C A Seipp; S M Steinberg; D E White; S A Rosenberg
Journal:  Arch Surg       Date:  1986-12

7.  Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas.

Authors:  R D Lindberg; R G Martin; M M Romsdahl; H T Barkley
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

8.  The prognostic value of histologic subtypes in primary extremity liposarcoma.

Authors:  H R Chang; S I Hajdu; C Collin; M F Brennan
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860

9.  Preoperative radiation therapy for sarcoma of soft tissue.

Authors:  H D Suit; K H Proppe; H J Mankin; W C Wood
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

10.  Low-grade soft tissue sarcomas of the extremities. Analysis of risk factors for metastasis.

Authors:  J H Donohue; C Collin; C Friedrich; J Godbold; S I Hajdu; M F Brennan
Journal:  Cancer       Date:  1988-07-01       Impact factor: 6.860

View more
  9 in total

1.  Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

Authors:  K G Billingsley; M E Burt; E Jara; R J Ginsberg; J M Woodruff; D H Leung; M F Brennan
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

2.  The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.

Authors:  Fritz C Eilber; Frederick R Eilber; Jeffery Eckardt; Gerald Rosen; Elyn Riedel; Robert G Maki; Murray F Brennan; Samuel Singer
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

3.  Multifocal myxoid liposarcoma--metastasis or second primary tumor?: a molecular biological analysis.

Authors:  Ronald de Vreeze; Daphne de Jong; Petra Nederlof; Henrique J Ruijter; Lucie Boerrigter; Rick Haas; Frits van Coevorden
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

Review 4.  Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma.

Authors:  M A Gadd; E S Casper; J M Woodruff; P M McCormack; M F Brennan
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

Review 5.  Lipomatous tumours of soft tissues: an update.

Authors:  T Mentzel; C D Fletcher
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  The role of multimodality therapy in soft-tissue sarcoma.

Authors:  M F Brennan; E S Casper; L B Harrison; M H Shiu; J Gaynor; S I Hajdu
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

7.  Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years.

Authors:  Carolin Knebel; Ulrich Lenze; Florian Pohlig; Florian Lenze; Norbert Harrasser; Christian Suren; Jonathan Breitenbach; Hans Rechl; Rüdiger von Eisenhart-Rothe; Heinrich M L Mühlhofer
Journal:  BMC Cancer       Date:  2017-06-12       Impact factor: 4.430

8.  Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma.

Authors:  Rosalvo Zósimo Bispo Júnior; Olavo Pires de Camargo; Cláudia Regina G C M de Oliveira; Renée Zon Filippi; André Mathias Baptista; Marcelo Tadeu Caiero
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

9.  Analysis of lung metastases in patients with primary extremity sarcoma.

Authors:  N Songür; M Dinç; C Ozdilekcan; S Eke; U Ok; M Oz
Journal:  Sarcoma       Date:  2003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.